CLINICAL COURSE OF TUBERCULOUS MENINGITIS IN THE CONTEXT OF HIV INFECTION

Main Article Content

Abstract:

Tuberculous meningitis is one of the most severe forms of tuberculosis and poses a significant life-threatening risk, particularly for patients living with HIV. HIV-associated immunodeficiency markedly alters the pathogenesis and clinical progression of the disease, resulting in atypical presentations, rapid progression, and a high incidence of severe neurological complications. Patients often present with prolonged fever, headache, changes in mental status, and focal neurological deficits, while classical meningeal signs may be less noticeable, leading to delays in diagnosis. Laboratory and cerebrospinal fluid findings are frequently nonspecific, and distinguishing the disease from other opportunistic central nervous system infections remains a major diagnostic challenge. Early recognition of tuberculous meningitis, timely initiation of appropriate antimicrobial therapy, and careful management of antiretroviral treatment-including prevention and control of immune reconstitution inflammatory syndrome-are critical for improving clinical outcomes in HIV-infected patients.

Article Details

How to Cite:

Kuldoshov , A. . (2025). CLINICAL COURSE OF TUBERCULOUS MENINGITIS IN THE CONTEXT OF HIV INFECTION. Eurasian Journal of Academic Research, 5(12), 123–129. Retrieved from https://in-academy.uz/index.php/ejar/article/view/69215

References:

Sánchez Portocarrero, J., Pérez Cecilia, E., Jiménez Escrig, A., Martín Rabadán, P., Roca, V., Ruiz Yague, M., Romero Vivas, J., & Palau, E. Tuberculous meningitis: Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol. 1996;53(7):671 676. doi:10.1001/archneur.1996.00550070109018.

Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta analysis. BMC Public Health. 2024;24:2145. This study examines the epidemiological burden of TBM among people living with HIV (PLWH), including prevalence, incidence, and mortality rates.

HIV Tuberculous Meningitis Co Infection: A Systematic Review and Meta Analysis. This systematic meta analysis assessed the pooled prevalence of TBM HIV co infection across published studies and emphasized the high rate of co infection and the need for concerted management strategies.

HIV associated tuberculous meningitis—diagnostic and therapeutic challenges. This review article discusses the clinical presentation, diagnostic challenges, and therapeutic issues in HIV associated TBM compared to HIV uninfected TBM.

Tuberculous meningitis in HIV infected individuals. This clinical review outlines how immunosuppression influences presentation, imaging findings, CSF culture sensitivity, and outcomes in HIV positive TBM patients.

Mortality in hospitalized patients with tuberculous meningitis. BMC Infectious Diseases. 2018. This cohort study evaluated predictors of poor outcomes in TBM, noting particularly worse prognosis in HIV infected patients with low CD4 counts and severe presentations.

Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. This retrospective study from a high HIV/TB co infection region highlights the impact of ART on survival and underlines the importance of early combined therapy.

Stadelman, A. M., Grint, D., et al. Treatment Outcomes in Adult Tuberculous Meningitis: A Systematic Review and Meta analysis. Open Forum Infectious Diseases. 2020;7(8):ofaa257. This meta analysis provides pooled mortality and disability data, showing significantly higher mortality in HIV positive TBM adults compared to HIV negative adults.

Jain, S., Tobin, D., Tucker, E., Venketaraman, V., Ordonez, A., Jayashankar, L., Siddiqi, O., Hammoud, D., et al. Tuberculous meningitis: a roadmap for advancing basic and translational research. Nat Immunol. 2018;19(6):521 525. (cited in systematic reviews).

Marais, S., Thwaites, G., Schoeman, J., Török, M., Misra, U., Prasad, K., Donald, P., Wilkinson, R., Marais, B. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803 812. (cited in systematic reviews).

Wilkinson, R., Rohlwink, U., Misra, U., van Crevel, R., Mai, N., Dooley, K., Caws, M., Figaji, A., Savic, R., Solomons, R., et al. Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581 598. (cited in systematic reviews on pathophysiology and clinical course).